Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_assertion type Assertion NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_head.
- NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_provenance.
- NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_assertion evidence source_evidence_literature NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_provenance.
- NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_assertion SIO_000772 23497317 NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_provenance.
- NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_assertion wasDerivedFrom befree-20150227 NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_provenance.
- NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_assertion wasGeneratedBy ECO_0000203 NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_provenance.